Preview

User

Not a user? Register with this site Forgot your password?

Rheumatology Science and Practice

Advanced search
Fullscreen

For citations:

Lapkina N.A., Baranov A.A., Abaytova N.E., Leontyeva E.A., Yaltseva N.V., Shutov A.S., Nasonov E.L. Experience with the interleukin 6 inhibitor (Olokizumab) in patients with rheumatoid arthritis in real clinical practice: Influence on inflammatory activity and disease outcomes. Rheumatology Science and Practice. 2023;61(5):554-561. (In Russ.) https://doi.org/10.47360/1995-4484-2023-554-561



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

 Processing of personal data
supported by NEICON (Elpub lab)